Financial Year |
March 31 2023 |
Monetary Funds |
230,088,634.06 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
32,093,320.50 |
Accounts Receivable |
465,237,326.65 |
Advances to Suppliers |
18,066,449.22 |
Other Receivables |
50,700,396.86 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
524,583,704.27 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
24,902,819.20 |
Total Current Assets |
1,351,135,266.86 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
1,617,526,689.40 |
Under-construction Projects |
377,842,011.08 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
178,362,693.59 |
R&D expenses |
31,136,771.53 |
Goodwill |
21,681,872.13 |
Long-Term Deferred and Prepaid Expenses |
26,392,709.74 |
Deferred Income Tax Assets |
30,061,632.25 |
Other Non-Current Assets |
64,392,094.85 |
Sub-Total of Non-Current Assets |
2,461,505,009.51 |
Total Assets |
3,812,640,276.37 |
Short-Term Loans |
874,004,240.34 |
Trading Financial liabilities |
-- |
Notes Payable |
30,988,797.33 |
Accounts Payable |
351,379,610.96 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
67,828,946.47 |
Taxes Payable |
14,863,806.20 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
21,911,778.12 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
78,133,593.02 |
Other Current Liabilities |
9,026,782.68 |
Sub-Total of Current Liabilities |
1,462,958,072.19 |
Long-term Loans |
427,948,148.62 |
Bonds Payable |
396,826,633.19 |
Long-Term Accounts Payable |
1,995,668.74 |
Special Payable |
-- |
Estimatied Liabilities |
1,161,411.12 |
Deferred Income Tax Liabilities |
10,491,281.55 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
943,509,951.42 |
Total Liabilities |
2,406,468,023.61 |
Paid-In Capital(Or Share Stock) |
287,104,605.00 |
Capital Surplus |
362,099,662.79 |
Surplus Reserve |
87,500,869.27 |
LESS:Treasury Stock |
9,999,244.82 |
Undistributed Profits |
531,785,061.32 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,406,172,252.76 |
Owner's Equity(Stockholder's Equity) |
1,406,172,252.76 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,812,640,276.37 |